欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/6351/001
药品名称Apixaban-ratiopharm 2,5 mg Filmtabletten
活性成分
    • APIXABAN 2.5 mg
剂型Film-coated tablet
上市许可持有人ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
参考成员国 - 产品名称Germany (DE)
Apixaban-ratiopharm 2,5 mg Filmtabletten
互认成员国 - 产品名称
    • Portugal (PT)
    • Denmark (DK)
    • Belgium (BE)
      Apixaban Teva Generics 2,5 mg filmomhulde tabletten
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
      Apixaban Teva
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Apixaban Teva
    • Latvia (LV)
      Apixaban Teva 2,5 mg apvalkotās tabletes
    • Lithuania (LT)
      Apixaban Teva 2,5 mg plėvele dengtos tabletės
    • Estonia (EE)
      APIXABAN TEVA
    • Hungary (HU)
    • Bulgaria (BG)
      Apixaban Teva
    • Czechia (CZ)
      Apixaban Teva
    • Romania (RO)
      Apixaban Teva 2,5 mg comprimate filmate
    • Slovakia (SK)
      Apixaban Teva 2,5 mg
    • Slovenia (SI)
    • Croatia (HR)
      Apiksaban Teva 2,5 mg filmom obložene tablete
许可日期2020/10/21
最近更新日期2024/04/17
药物ATC编码
    • B01AF02 apixaban
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase